XORI CORP
Profile
Company Names
XORI CORP
Addresses
1616 EAST LAKE AVE, E, SUITE 205, SEATTLE, WA 98102
Phone Numbers
206-957-7300
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2009
State Incorporated:
DE
Total Amount Raised:
$2,102,396.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2009-05-01
$2,102,396.00
$4,522,201.00
$2,419,805.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRED
ESHELMAN
DIRECTOR
STEVE
GILLIS
DIRECTOR
XORI CORP
| ONCOFACTOR CORP
| VARIATION BIOTECHNOLOGIES (US), INC.
| LYCERA CORP
| VBI VACCINES INC.
| ONCORESPONSE INC
| LODO THERAPEUTICS CORP
| PETRA PHARMA CORP
| APOGEN BIOTECHNOLOGIES, INC.
| RODEO THERAPEUTICS CORP
| PRONIRAS CORP
| MAGNOLIA NEUROSCIENCES CORP
| VBI VACCINES INC/BC
| ALLY THERAPEUTICS, INC.
| SKYLARK BIO, INC.
| BASKING BIOSCIENCES, INC.
THONG
LE
DIRECTOR
LINDSAY
RAYLE
EXECUTIVE OFFICER
DAVID
SCHUBERT
EXECUTIVE OFFICER
CHAD
WAITE
DIRECTOR
CARL
WEISSMAN
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

